This section presents medications that are known to potentially lead to 'Epidermal necrosis' as a side effect. It's important to note that mild side effects are quite common with medications. Please ...
Researchers identified early signs and risk factors of methotrexate-induced epidermal necrosis, and physicians should use caution when deciding when to prescribe methotrexate to high-risk patients, ...
Toxic epidermal necrolysis (TEN) counts among the acute epidermolytic dermopathies. The nomenclature of these skin disorders is confusing since various overlapping definitions exist. According to a ...
Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug reaction characterized by widespread epidermal necrosis and detachment. It results in severe morbidity, with mortality rates of up to ...
Please provide your email address to receive an email when new articles are posted on . The addition of a tumor necrosis factor inhibitor to steroid therapy reduced acute stage disease duration and ...
The researchers used spatial proteomics to analyze skin samples from patients with toxic epidermal necrolysis. This cutting-edge approach, known as Deep Visual Proteomics, merges powerful microscopy ...
The patient was a 1580 g female born at 35 5/7 weeks gestation to a 24-year-old mother. Parents were consanguineous and had lost three prior pregnancies to miscarriage. Mother had known protein S ...
Epidermal necrolysis (EN) — which includes Stevens-Johnson syndrome (SJS), toxic EN (TEN), and SJS and TEN overlap — had an incidence of 2.6 cases per million person-years in a French study of adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback